Drug intelligence / Profile preview

Tianji 999

Development stage
Unknown
Lead developer
China Resources Sanjiu Medical & Pharmaceutical
Modality
Small Molecules
Administration
Oral
01

Overview

"Tianji 999" (or simply Tianji) is a trade brand utilized by China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (CR Sanjiu) for its portfolio of specialty pharmaceutical products in China. The brand encompasses a diverse range of generic small molecule drugs across several therapeutic areas, most notably oncology, supportive care, cardiovascular medicine, and hepatology. Key products marketed under the Tianji label include **ondansetron hydrochloride** (a selective 5-HT3 receptor antagonist used as an antiemetic), **gefitinib** (an EGFR tyrosine kinase inhibitor for non-small cell lung cancer), **bicalutamide** (an androgen receptor antagonist for prostate cancer), **amlodipine besylate** (a calcium channel blocker for hypertension), and **entecavir** (a nucleoside analog for hepatitis B). The brand is particularly recognized for its oncology supportive care offerings, such as the orally disintegrating tablet formulation of ondansetron. Because the name refers to a commercial product line rather than a single chemical entity, its clinical application and mechanism of action are non-specific and depend on the specific medication within the Tianji portfolio.

Brand names
Tianji999 TianjiTianji 999Tianji999Tianji-999
02

Targets

EGFR (Epidermal growth factor receptor)HBV Pol (Hepatitis B virus polymerase)HTR3A (5-hydroxytryptamine receptor 3A)LTCC (Voltage-gated calcium channel (L-type))AR (Adrenergic receptors)

Beyond the preview

Go deeper on Tianji 999.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tianji 999.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call